Kaplan‐Meier survival analysis revealed that the DFS (stages I–III) and OS (stage IV) in GC patients with lower MACC1 expression levels were prolonged compared with those who had higher MACC1 expression (p = 0.0076, p = 0.0248; Figure 5C,D), while SPINT1 showed an opposite impact on these outcomes. This evidence concerns the gene MACC1 and gastric cancer.